Iranian Journal of Public Health 2017. 46(10):1448-1449.

Forecasting the Incidence of Testis Cancer in Europe from 2012-2035


No Abstract

Full Text:



Ferlay J, Soerjomataram I, Dikshit R et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136(5): E359-86.

Magelssen H, Brydøy M, Fosså SD (2006). The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Oncol, 3(6):312-22.

Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide.

Ross R, McCurtis J, Henderson B et al (1979). Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer, 39(3):284-9.

Osterlind A (1986). Diverging trends in inci-dence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer, 53(4):501-05.

Power D, Brown R, Brock C et al (2001). Trends in testicular carcinoma in England and Wales, 1971–99. BJU Int, 87(4):361-5.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J, Comber H, Forman D, Bray F(2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49(6):1374-403.

Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F(2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.